Active — Not RecruitingNot Applicable

An Evaluation of Patient Reported Outcomes and Clinical Outcomes

United States379 participantsStarted 2023-10-16

Plain-language summary

This extension study is being conducted to assess the following objectives through 12 months post-cardiac surgery: * Patient reported outcomes (PRO), using the EQ-5D questionnaire * Clinical outcomes

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Subjects must have completed the REN-007 study to be eligible to participate in the Extension Study. Exclusion Criteria: * Subjects who did not complete the REN-007 study are not eligible to participate in the Extension Study. * Female subjects who become pregnant during the REN-007 study are not eligible to participate in the Extension Study.

What they're measuring

Evaluation

Timeframe: 12 Months Post-Cardiac Surgery

Evaluation

Timeframe: 12 Months Post-Cardiac Surgery

Trial details

NCT IDNCT06092970

SponsorRenibus Therapeutics, Inc.

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2026-06-30

View on ClinicalTrials.gov More Post-Operative Complications in Cardiac Surgery trials